JWH 182 is primarily researched for its interaction with cannabinoid receptors, particularly CB1 and CB2, which makes it relevant in studies related to the endocannabinoid system. Its application is largely confined to scientific research, where it is used to explore the pharmacological effects of synthetic cannabinoids. Researchers utilize it to understand the binding mechanisms and the potential therapeutic or adverse effects of cannabinoid receptor agonists. It is also studied in the context of substance abuse to better comprehend the impact of synthetic cannabinoids on the brain and behavior. Due to its psychoactive properties, it is not used in medical or commercial products but remains a subject of interest in neuroscience and pharmacology.